New drug RBD1119 put to the test in healthy volunteers
Knowledge-focused
Ongoing
This early-stage study tests a single injection of a new drug, RBD1119, in 32 healthy adults aged 18 to 65. The main goal is to check for side effects and see how the drug moves through the body. Participants are randomly assigned to receive either the drug or a placebo, and no o…
Phase: PHASE1 • Sponsor: Suzhou Ribo Life Science Co. Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC